Evoke Pharma Inc expected to post a loss of 72 cents a share - Earnings Preview

Evoke Pharma

13/08/2024 08:34

* Evoke Pharma Inc  EVOK.OQ   EVOK.O  is expected to show a
rise
in quarterly revenue when it reports  results on August 15 for
the period ending June 30 2024
    * The Solana Beach California-based  company is expected to
report
a 163.5% increase in revenue to $2.98 million from $1.13 million
a year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Evoke Pharma Inc is for
a loss
of 72 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated August 13 at 07:34 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)